Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Horvath

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Trials|January 23, 2021
Effect of early sleep apnoea treatment with adaptive servo-ventilation in acute stroke patients on cerebral lesion evolution and neurological outcomes: study protocol for a multicentre, randomized controlled, rater-blinded, clinical trial (eSATIS: early Sleep Apnoea Treatment in Stroke)Simone B Duss, Anne-Kathrin Brill, Sébastien Baillieul, et al.
Journal of Stroke|June 10, 2025
Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial AnalysisAlexandros A Polymeris, Masatoshi Koga, Daniel Strbian, et al.
Journal of Stroke|June 10, 2025
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial FibrillationMasatoshi Koga, Mattia Branca, Daniel Strbian, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
JAMA Neurology|May 28, 2024
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialMartina B Goeldlin, Arsany Hakim, Mattia Branca, et al.
Circulation|May 16, 2024
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN TrialRoman Rohner, Markus Kneihsl, Martina B Goeldlin, et al.
The New England Journal of Medicine|May 24, 2023
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Masatoshi Koga, Daniel Strbian, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Trials|January 23, 2021
Effect of early sleep apnoea treatment with adaptive servo-ventilation in acute stroke patients on cerebral lesion evolution and neurological outcomes: study protocol for a multicentre, randomized controlled, rater-blinded, clinical trial (eSATIS: early Sleep Apnoea Treatment in Stroke)Simone B Duss, Anne-Kathrin Brill, Sébastien Baillieul, et al.
Journal of Stroke|June 10, 2025
Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial AnalysisAlexandros A Polymeris, Masatoshi Koga, Daniel Strbian, et al.
Journal of Stroke|June 10, 2025
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial FibrillationMasatoshi Koga, Mattia Branca, Daniel Strbian, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
JAMA Neurology|May 28, 2024
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialMartina B Goeldlin, Arsany Hakim, Mattia Branca, et al.
Circulation|May 16, 2024
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN TrialRoman Rohner, Markus Kneihsl, Martina B Goeldlin, et al.
The New England Journal of Medicine|May 24, 2023
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Masatoshi Koga, Daniel Strbian, et al.
Pageof 4